Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)P Dodion, T A Davis, M Rozencweig, et al.
Investigational New Drugs|January 1, 1986
Phase I study of oral idarubicin given with a weekly scheduleP Dodion, C Finet, N Crespeigne, et al.
American Journal of Clinical Oncology|December 1, 1987
Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovaryM Staquet, B W Brown, M Rozencweig, et al.
British Medical Journal|June 28, 1975
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. studyJ C Heuson, E Engelsman, J Blonk-Van Der Wijst, et al.
British Medical Journal|June 28, 1975
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. studyE Engelsman, J C Heuson, J Blonk Van Der Wijst, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assayP Dodion, C Sanders, W Rombaut, et al.
Investigational New Drugs|January 1, 1986
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivativesD Bron, P Dodion, M Rozencweig, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: preliminary results of a double-blind randomized study of the EORTC Breast Cancer Cooperative GroupR Paridaens, J C Heuson, J P Julien, et al.
Oncology|January 1, 1976
Neocarzinostatin (NSC 157365) a new cancerostatic compoundS S Legha, D D Von Hoff, M Rozencweig, et al.
The Journal of Endocrinology|May 1, 1977
Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatmentA Borkowski, M L'hermite, P Dor, et al.
Pageof 13